Dr. Lal Path Labs Ltd reported Q2 FY27 revenue of Rs. 874 crore, up 19.6%, and PAT of Rs. 194 crore, up 27.5%, with a 22.2% margin. Management expects FY27 revenue growth in the high teens and full-year EBITDA margin slightly above 27.2%.

5 source passages

Revenue for Q2 FY27 came in at Rs. 874 crore compared to Rs. 731 crore in the same quarter last year, reflecting a growth of 19.6%. PAT for Q2 FY27 came in at Rs. 194 crore compared to Rs. 152 crore in the same quarter last year, registering a growth of 27.5% with a PAT margin of 22.2%. I think last year, full year, our EBITDA was 27.2%. I think this year, we should be slightly better than that. Full year. We are looking at maybe FY27 numbers in high-teen growth. Open the document at this passage

Jul 24

Earnings call

Q1 2027 earnings call AI summary on its way

Apr 30

Earnings call

Q4 2026 earnings call AI summary on its way

Showing 1–3 of 3 documents